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ENHANCED PENETRATION OF LIPID FUNCTIONALIZED NANOPARTICLES IN 3D CELL 
CULTURES 
Christopher G. England 
June 21, 2013 
Nanoparticle-based systems can  alleviate systemic toxicity via surface functionalization to promote tissue-
specific targeting as well as passive targeting abilities [1], such as the enhanced permeation and retention 
effect (EPR) [2]. The transport of nanoparticles is limited in hypoxic tumor regions due to the typically 
impaired tumor vasculature. To enhance diffusion of nanotherapeutics within tumor tissue; functionalized 
citrate gold nanoparticles and silica gold nanoshells with surface modifications of phosphatidylcholine (PC) 
and high density lipoprotein (HDL) were synthesized.  3D cell cultures were used as a representative model 
of portions of hypoxic tissue in liver, lung, and pancreatic solid tumors. Our results indicate that two 
layered silica gold nanoshells (surface modifications of –thiol and PC) permit enhanced accumulate 
compared to PEGylated nanoparticles. The addition of HDL for the smaller, citrate gold nanoparticles as a 
third external layer provided enriched accumulation compared to PEGylated nanoparticles.  In conclusion, 
nanoparticles functionalized with PC and HDL show superior accumulation in avascular tumor tissue in 
comparison to previously designed PEGylated nanoparticles.  
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The microenvironment within cancerous tissue is a critical barrier leading to the unsuccessful 
treatment of most solid tumors. Severity and lethality of many cancer forms have been decreasing during 
the last fifty years due to extraordinary breakthroughs in therapeutic treatment strategies. On the contrary,  
solid tumors of the lung, pancreas, and liver remain three of the most lethal forms of cancer in the United 
States [3]. Current functional chemotherapeutics and drug delivery mechanisms often fail to cure patients. 
For this reason, novel treatment modalities are critically needed in the clinic, promoting the extension of 
five-year survival rates along with enhanced quality of life. In the United States, cancer is now the leading 
cause of death claiming the lives of 1,600 people per day [3], illustrating the dire need for supplemented or 
modified treatment strategies to promote survival in patients. This study examines the penetration and 
diffusion capabilities of lipid functionalized nanoparticles as a potential methodology for enhancing the 
delivery of vital chemotherapeutic agents deeper into solid tumor tissue. This enhanced delivery will 
promote therapeutic levels of drug exposure to portions of tumor normally experiencing sub-optimal 
chemotherapeutic levels. This study examines the diffusion capabilities of lipid functionalized 
nanoparticles, providing the necessary foundation for future studies in drug delivery.  To enhance tumor 
uptake of nanoparticles, nanoparticle were functionalized with either two- or three layers consisting of 
phosphatidylcholine and HDL. 3D cell cultures of A549 (human lung carcinoma), S2VP10 (human 
pancreatic adenocarcinoma), and HepG2 (liver hepatocellular carcinoma) were used to analyze the 
penetration and diffusion capabilities of lipid-functionalized nanoparticles within hypoxic portions of 
avascular tumor tissue.  
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HOSTILE MICROENVIRONMENT OF SOLID TUMORS 
 
 
The human body is constructed ensuring all normal cells are located within a few cell diameters of 
blood supply. This promotes normal cellular function for each of the ~10
13
 cell found in each person [4, 5]. 
While this complex system holds true for normal tissue, the ideology collapses when cellular proliferation 
increases at higher rates than the endothelial cells that form blood capillaries, as in most solid cancerous 
tumors [5, 6] . This enhanced proliferating of cells and decreased apoptotic rate eventually reduces vascular 
density, leading to areas of tumor experiencing hypoxia, poor perfusion, and high permeability [7, 8]. 
These hypoxic portions of tumor tissue lacking the needed pO2 are normally formed when cells are located 
~100-200μm from the nearest blood vessel, yet this can vary based upon the type of solid tumor [5, 9]. 
Other than hypoxia, the surrounding tissue is also subjected to increased interstitial fluid pressure (IFP) 
from the irregular vasculature and lack of lymphatic vessels, along with decreased extracellular pH due to 
the buildup of metabolic waste products such as lactic and carbonic acid [5, 10].  For these reasons, the 
hostility of the tumor microenvironment is a strong determinant of successful clinical treatment and a 




Figure 1: Histology of Normal and Cancerous Pancreatic Tissue.  SCID mice injected with S2VP10L were 
euthanized and organs were retrieved and sectioned for histological analysis. (A) Normal pancreatic tissue 
illustrating the organized vasculature providing the necessary oxygen and nutrients to the surrounding 
tissue composed of serous acini and zymogenic cells, along with pancreatic islets and specialized ducts. (B) 
Cancerous pancreatic tissue depicts a disorganized array of cells with a lack of blood vessels supporting the 
vast amount of tissue. For this entire portion of tissue, there is only a few blood vessels supplying nutrients 
and oxygen. (C) Depiction of both non-cancerous and cancerous tissue shows the lack of cellular 
organization from the normal tissue (left) to the cancerous tissue (right), with necrosis portions of tissue 
forming from lack of oxygen. (D) The CD17 stain intensifies the color surrounding vasculature with the 
arrows depicting blood vessels found in the pancreatic tissue [11].  
 
 Generally, there are three accepted hypotheses denoting why cells distant from vasculature may 
acquire increased resistance to conventional chemotherapeutic regimens. First, cells residing within 
hypoxic microenvironments normally alter their metabolic activity to promote survival while experiencing 
deficient concentrations of oxygen and other nutrients [12-14]. This alteration in metabolic activity may 
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lead to cellular quiescence, in which cell ceases division and enters a period of resting [5]. During the G0 
portion of the cell cycle, cell-cycle specific chemotherapeutics designed for instigating selective toxicity 
during certain phases of the cell cycle such as the S-, M- or G-phase will not provide therapeutic benefits 
[15, 16].  
Secondly,  hypoxic portions of tumor also experience other harsh conditions such as  ischemia 
(lack of nutrients) and increased extracellular pH levels leading to acidic microenvironments [5]. Drug 
efficacy can be effected by factors such as pH, which can alter the ionization of some drugs possibly 
causing drug-inactivation [15]. Lastly, the filamentous extracellular matrix (ECM) and other components of 
the hostile microenvironment may hinder overall delivery of chemotherapy drugs (including nanoparticles) 
to hypoxic portions of solid tumor [5, 6, 17]. This decreased accumulation of drugs (and nanoparticles) 
within the solid tumor leads to suboptimal chemotherapeutic exposure not reaching the minimum inhibitory 
concentration needed to produce a therapeutic response [2, 18]. Overall, the concentration gradients of 
oxygen and other nutrients, as illustrated in Figure 2, must be considered when designing novel 







Figure 2: Concentration Gradients Found in Solid Tumors. The microenvironment found in solid tumors is 
different from normal tissue. Cells distant from vasculature receive decreased amounts of oxygen, 
nutrients, drug availability, energy, and pH (promoting an acidic environment). These distant cells can 
experience hypoxia leading to cellular quiescence, along with tissue necrosis due to an increased interstitial 
fluid pressure and other factors [5]. Illustration created by author. 
 
 The tumor microenvironment is used for the exchange of information in normal and cancerous 
tissues through cell-cell contacts, cytokines, and the ECM [19]. The tumor microenvironment is composed  
of multiple components including immune cells, along with stromal fibroblasts and epithelial cells 
providing the structural scaffolding of the tissue [19]. The variable combination of numerous cell types 
(such as immune cells, fibroblasts, and endothelial cells) better depict the tissue found in solid tumors and 
the microenvironment within this tissue [20]. Drug efficacy testing is normally completed using monolayer 
cell cultures because of wide-spread availability and ease of use, yet monolayer cell cultures do not portray 
the same type of tissue found in vivo due to the lack of ECM components, diffusion gradients of nutrients,  
and various cell types [21]. In conclusion, the hostile microenvironment, along with irregular vasculature, 
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of solid tumors hinder the transport of drug and other molecules (such as nanoparticles) within tumor tissue 
causing suboptimal chemotherapeutic exposure and therapeutic failure [2, 7, 20].
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3D CELL CULTURES IN RESEARCH 
 
 
3D cell cultures provide additional spatial information for studying the microenvironment of solid 
tumors as they have the ability to form ECM components along with realistic morphology similar to that 
found in vivo [22, 23]. Since the growth and treatment response of solid tumors is critically influenced by 
their microenvironment, this interaction is crucial for studying parameters such as hypoxia and drug or 
nanoparticle delivery in 3-dimensions [24]. Monolayer cell cultures have been the most widely employed 
method of accessing drug efficacy and toxicity in vitro [22, 25-29]. The animal model has the advantage of 
reproducing the clinical effects, yet remains costly and time-consuming. 3D cell cultures provide a unique 
advantage over in vivo models by eliminating many of the complicating factors such as immune cell 
interaction, first-pass effect, and urinary excretion  [30]. 3D cell cultures promote the development of an 
ECM, tight junctions between the epithelia cells, gradients of nutrients concentration, and gradients of cell 
proliferation from the exterior to the interior of the tumor [5, 28, 31]. These cell cultures can produce 
spheroids up to 1mm in size with larger spheroids becoming hypoxic with necrotic cores, qualities similar 
to those found in solid tumors [5, 9].  
While monolayer cell cultures have been used greatly in the past, the advantages to using 3D cell 
are clearly visible and supported by research. Many groups have studies the similarities between growing 
traditional monolayer 2D cell cultures in comparison to the 3D method. For example, scientists were able 
to determine that transformed lung cells grown in 3D conditions displayed cellular markers more closely 
resembled to the animal model compared to the traditional monolayer cell cultures. This study also 
indicated that cellular differentiation of 3D cell cultures were more closely related to animal model as 
compared to monolayer cell cultures  [32, 33]. Experiments with 3D cell cultures have helped to analyze 
the effect of physical barriers on optimal drug delivery in comparison to monolayer studies [34-36], e.g., 
the impact of the extracellular matrix was studied by Goodman et al. who demonstrated an increased 
penetration of nanoparticles treated with collagenase in 3D cell cultures [36].  
 Overall, there are four crucial features of 3D cell cultures illustrating their superiority in 
comparison to monolayer cell cultures. The first feature is the ability of 3D cell cultures to reestablish 
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morphological, functional, and mass transport features of the corresponding tissue found in vivo [21, 37, 
38]. It was shown that 3D cell cultures can maintain some of the differentiation patterns found in animals 
models for weeks [37]. These features are created and maintained by the tumor cell-derived ECM along 
with the cellular interactions, e.g. cell-cell and cell-matrix interactions [21]. Both of these interactions are 
absent from monolayer cell cultures giving rise to the possibility of using 3D cell cultures for studies 
involving drug penetration in tumors, binding of certain biological agents, and drug bioactivity. Secondly, 
the 3D cell cultures can mimic many characteristics of the avascular tumor nodules, micro-metastases, or 
intravascular regions of large solid tumors [21, 37]. 3D cell cultures form gradients in which proliferating 
cells are found toward the periphery with quiescent cells found in the center. This suggests that cells 
experiencing cell-cycle arrest will be further into the tumor core exhibiting necrosis [21]. The necrotic cells 
are located in spheroids possessing a diameter greater than 500 µm allowing scientists to study solid tumor 
necrosis, hypoxia, and ischemia [21, 37, 39].   
 Next, the well-defined spherical geometry of the 3D cell cultures provides an easy representative 
model that can be expressed mathematically for computational analysis. The unique structure produced by  
3D cell cultures also allows for direct comparison of structure to function, allowing for studies of drug 
response that can be localized within the tumor microenvironment [6, 37]. In reality, diffusion gradients of 
various components (nutrients, drugs, nanoparticles, etc.) can be studied using 3D cell cultures [6, 21]. 
Lastly, 3D cell cultures provide the unique opportunity for co-culturing of various cell types due to 
clustering effects [40, 41]. For example, scientists have shown that co-cultures containing A549 cancer 
cells, THP-1 macrophages, HMC-1 mast cells, and EAHY926 endothelial cells, more closely mimicked the 
actual tumor experience found in vivo compared to the A549 single cell cultures [40]. Local effects of 
differential cells can cause catastrophic differences in therapy response providing vital details about 
interactions between the immune system and cancerous tumors [40, 42].   It is important to understand the 
solid tumor on a larger scale rather than one type of cell.  While 3D cell cultures have great benefits, this 
system also has downfalls. For example, 3D cell cultures require costly culturing plates and equipment to 
form the culture. In conclusion, 3D cell cultures provide a more realistic approach for studying nanoparticle 
(or drug) penetration and diffusion within tissue.
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NANOPARTICLES IN CANCER THERAPY 
 
 
Advances in nanotechnology have provided enhanced targeting and efficient transport of 
chemotherapeutic drugs into solid tumors. Studies have shown that nanotherapeutics may provide new 
hope for patients due to their ability to deliver an increased concentration of drug to tumor tissue that is 
protected from environmental degradation through active targeting of specific receptors up-regulated in 
cancerous tissue. Nanotherapeutics also provide the ability to bypass resistance mechanisms like MDR 
(such as P-glycoprotein), while also avoiding immune cells of the reticuloendothelial system (RES) [43-
47].  
Since traditional chemotherapeutics may be unable to bypass the physical barriers and resistance 
mechanisms offered by the microenvironment and cells in solid tumors, there is a critical need for new 
methodologies. There are several nano-based therapies in clinical use or in clinical trials including FDA 
approved Abraxane® for the treatment of lung cancer [48],  the investigational lipid nanoparticles 
containing siRNA ALN-VSP for the treatment of liver cancer [49], and multiple polymeric nanoparticles 
containing platinum drugs for the treatment of multiple cancer types including pancreatic cancer [49]. The 
FDA approved drug Doxil® is a PEGylated liposomal carrier encapsulating doxorubicin that is used for 
ovarian cancer and multiple myeloma [48, 50].  
Cancer specificity can be altered through the functionalization process of nanoparticle synthesis, 
yielding novel treatment modalities for liver, lung, and pancreatic cancer.  The addition of targeting ligands 
(boronic acid proteins, galactosamine, glycyrrhetinic acid, galactose, lactosyl-norcantharidin, bovine serum 
albumin, monoclonal anti-MT1-MMP antibody, anti-VEGF, etc. ) to the surface of nanoparticle have 
enhanced the delivery of drugs such as docetaxel, oridonin, sodium ferulate, doxorubicin, siRNAs, 5-
fluorouracil, and paclitaxel to the liver [10, 23, 51-63]. These studies have shown the possibility of using 
specific ligands to promote active targeting to hepatocytes, while avoiding surrounding healthy tissue. 
While liver and pancreatic cancer chemotherapeutics must be given through intravenous injection (I.V.), 
the inhalation route of administration in lung cancer can provide both localized and systemic actions. 
Inhalable nanoparticle powders (such as lactose and chitosan-PLGA) containing therapeutic agents such as 
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doxorubicin, calcitonin, itraconazole, and rifampicin have shown localized benefit in the treatment of lung 
cancer [64-68]. While beneficial, there modified drugs have come with adverse effects through 
translocation of the nanoparticles from the lungs to other remote organs [64, 69-75]. The I.V. route of 
administration has shown promises in the treatment of lung cancer with active targeting to the lung by: 
targeting telomerase activity through potent telomerase inhibitors [76, 77],  delivery of siRNA to 
knockdown oncogenes such as mouse double minute 2 (MDM2) [78], enhancing gene delivery through 
using a bioadhesive stabilizer (Carbopol 940) or p53 [79, 80], and specifically targeting the EGFR 
overexpression for chemotherapeutic delivery [81-83].  
So far, the delivery of chemotherapeutics to cancerous cells of the pancreas has failed miserably 
with five year survival rates of only 6% [3]. Nano-based treatments for pancreatic cancer aim to deliver 
chemotherapeutic agents such as gemcitabine, cisplatin, tetraiodothyroacetic acid, gambogic acid, and 
metformin [84-87],  using targeting ligands to entities such as integrin αVβ3 receptor [88], matrix 
metalloproteinases [89], Herceptin (HER2) [90], EGFR [91], and fucosyltransferases [86]. While these 
studies have shown successful treatment of pancreatic cancer in vitro and in vivo, delivery of an effective 
dose of nanoparticles in human trials still remains deficient. 
Passive and active targeting of nanoparticles promote increased accumulation in tumor tissue due 
to the leaky tumor vasculature, the enhanced permeability and retention (EPR) effect, and selectivity for 
up-regulated receptors such as HDL [92-95]. In general, multiple studies have analyzed the possible 
toxicity from the accumulation of gold, yet the studies did not show any form of systemic toxicity [96, 97]. 
Through the process of functionalization, nanoparticles can be modified to promote active targeting and 
increase circulation time allowing for more uniform drug delivery [98-100]. The addition of surface 
modifications to nanoparticles can alter factors such as surface charge, circulation time, active targeting 
abilities, and retention effects [101]. Positively charged nanoparticles tend to improve the payload of drug 
delivered to cells while negatively charged nanoparticles seem to diffuse more quickly through the tissue 
[102]. There are various surface modifications that can be appended to form new variants of nanoparticles. 
The most common surface modification is PEGylation or the addition of poly(ethylene)glycol (PEG) [98-
100]. The addition of PEG promotes steric stabilization while hindering interaction with immune system 
cells of the mononuclear phagocyte system (MPS) [43, 98, 101]. The addition of phosphatidylcholine (PC) 
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onto the surface of gold nanorods was shown to decrease the amount of particle agglomeration as well as 
toxic effects [103]. The addition of high-density lipo-protein (HDL) has been studied due to an enhanced 
HDL-cholesterol uptake in many human cancers [104, 105].  
Once small nanoparticles extravasate from the tumor vasculature, their range of diffusion is a 
critical determinant of successful therapy. Wong et al. have demonstrated diffusion of nanoparticles in 
collagen gel [2], and Goodman et al. used fluorescent staining to determine approximate nanoparticle 
concentration in 3D cell culture [36]. Particle accumulation was shown to be size dependent by Huang et 
al. and others suggesting that particles ~20 nm or smaller had superior penetration abilities compared to 
larger particles [106-108].  Smaller particles (< 50 nm) are not as useful for drug delivery as compared to 
larger nanoparticles due to their small payloads and low EPR effect [106]. Huang et al. also demonstrated 
that 2 nm nanoparticles were able to reach inner portions of tumor spheroids better than larger particles, 
which was also confirmed in vivo [106]. Other groups such as Cabral et al. showed that larger polymeric 
micelles (>200 nm) were only able to diffuse within hyper-vascularized tumors, while only sub-100 nm 
particles were able to penetrate and diffuse through tumors experiencing hypoxia (hypo-vascularized) 
[108].     
In this study we examine the uptake of functionalized citrate gold nanoparticles (CGN) along with 
silica gold nanoshells (SGN) in 3D cell cultures. Performance of nanoparticles was evaluated in three 
different cancer cell lines including A549, S2VP10, and HepG2. The surfaces of CGN and SGN were 
functionalized through a two- or three-layering process to optimize uptake into tumor tissue. The two- layer 
particles were synthesized with an inner layer of -thiol and an outer layer of PC. In order to further 
optimize tumor uptake, active targeting was promoted by adding HDL on the exterior of the PC layer 
creating the three- layered nanoparticles.  The uptake and distribution of these nanoparticles in 3D cell was 







PARTICLE SYNTHESIS, FUNCTIONALIZATION, AND CHARACTERIZATION 
 
 
Synthesis of Citrate Gold Nanoparticles (CGN): CGN were synthesized using the gold citrate 
method in which gold chloroauric acid is reduced by trisodium citrate [109]. In this process, 2.2-2.4 mL 1% 
wt/v citrate (Fischer Scientific) and 200 mL 0.01% wt/v HAuCl4 (Alfa Aesar, MA) are mixed and heated to 
boiling, which promotes the reaction of sodium citrate to citric acid. Once the reaction is complete and 
allowed to cool, the solution is concentrated using a rotovapor (Buchi Rotovapor System) to ~20 mL before 
the addition of any layering. 
Synthesis of Silica Gold Nanoshells (SGN): SGN have an inner core composed of silica with an 
outer coating of gold [75, 110]. Synthesis of these particles follows the Stober method [111-114] consisting 
of four main stages: production of small gold seed particles, fabrication of monodispersed silica cores, 
attachment of gold to the seed particles, and gold shell growth. The gold colloid solution is created using 
the recipe from Duff, Langmuir 1993 [115]. Growth of the silica cores requires the combination of 7.5 mL 
tetraethyl-orthosilicate (Sigma Aldrich, 333859), 225 mL absolute ethanol (Decon Labs), and 12.5-13.5 mL 
ammonia (Sigma Aldrich) [56]. The amount of ammonia is adjusted to achieve silica core sizes 110 +/-5 
nm. After the paraffin cover is removed and the ammonia is evaporated, the cores are modified by coating 
with 3-4% aminopropyltriethoxysilane (APTES) (Sigma Aldrich, 440140). Once the seeds are washed, the 
10% gold solution (THPC) is added. After reaction time, the seeds are washed and the pellet is redispered 
in DI water. The optical density is measured (Varian Cary 50Bio UV-Visible Spectrometer) and the seeds 
are diluted to a lowOD (optical density) at 530 nm. Next, a sweep of the seeds is performed to optomize the 
chemical ratio between seeds, K2CO3-HAuCl4, and formaldehyde (Fischer Scientific F79). Once an optimal 
ratio is found, the reaction can be scaled up with appropriate amounts of THPC with seeds, Potassium 
Carbonate, and Formaldehyde [56]. 
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Particle Functionalization: The first layer applied to the CGN was hexadecathiol (Sigma Aldrich 
471364) dissolved in ethanol [52]. While stirring, 20 mL pure ethanol (Decon Labs) was placed in a 
breaker with 60 uL 1-Hexadecathiol being added secondly. The nanoparticles were added to the sample 
slowly dropwise. After agitating sample for 20 minutes, it was placed on an orbital rocker (Orbitron 
Rotator, Boekel Scientific)  for 12 hours. The sample was spun down and the pellet washed twice and 
resuspended in chloroform (Sigma Aldrich, 288360). The second was the addition of the PC (Avanti 
Lipids), a type of phospholipid that is a major component of biological membranes [73]. The PC (10 
mg/mL chloroform) stock solution was added to the particles after the -thiol layer and was allowed to set 
overnight on the orbital rocker. The solutions are transferred to glass tubes and the chloroform is 
evaporated at ambient temperature. This completed the two layer nanoparticles, and will be referred to as 
CAU/TL/PC (citrate gold/thiol/phosphatidylcholine) and NS/TL/PC (nanoshell/thiol/phosphatidylcholine).  
The next type of particle was synthesized after the addition of the PC. HDL from human plasma 
(Sigma Aldrich L1567)  was added to the particles to promote active targeting since HDL is highly 
expressed in various forms of cancer, as well as hepatocellular tissue [74, 116, 117]. After the addition of 
HDL, the nanoparticles were allowed to react overnight. The addition of the HDL layer yielded the three 
layer nanoparticle, referred to as CAU/TL/PC/LP and NS/TL/PC/LP.  
PEGylation of nanoparticles is considered the most common form of surface modification for 
delivering nanoparicles into cancdcerous tissue. In this study, PEGylated nanoparticles are used as the  
control to compare the efficacy of the newly synthesized two- and three layer nanoparticles. Numerous 
studies have shown that pegylated particles remain in the circulation longer than non-PEGylated 
nanoparticles [57]. For this study, the two types of layered particles, CAU/TL/PC or NS/TL/PC and 
CAU/TL/PC/LP or NS/TL/PC/LP, are compared to the CAU/PEG (citrate gold/pegylated) particles and 
NS/PEG. To create the pegylated particles, both the citrate gold nanoparticles and silica gold nanoshells are 
incubated with 2000 MW poly(ethylene)glycol overnight.   
Particle Characterization: Four methods were employed to ensure correct functionalization of the 
nanoparticles. (i) Particles were analyzed using the Varian Cory 50 Bio UV-Visible Spectrometer to obtain 
maximum absorption wavelengths. (ii) Size and zeta potential measurements were obtained using the 
ZetaSizer Nanoseries ZS90 from Malvera Instruments. (iii) Morphology and size of the nanoparticles were 
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determined using a Zeiss Supra 35VP scanning electron microscope (SEM). (iv) Presence of lipids on the 
surface of the particles was confirmed using the Fourier transform infrared (FTIR) (Perkin Elmer Spectrum 
BX) and through visual analysis using the SEM.
15 
 
CELL CULTURE WORK 
 
 
Cell Cultures: The human lung adenocarcinoma cell line A-549 and the liver hepatocellular 
carcinoma cell line HepG2 were maintained in Dulbecco’s modified Eagle’s medium (Sigma R0883) with 
10% fetal bovine serum (Atlanta Biologicals, GA) and 1% penicillin-streptomycin-glutamine solution 
(HyClone 100X, Thermo Scientific)  in a humidified atmosphere of 5% CO2 at 37˚ C (NAPCO Series 8000 
DH, Thermo Scientific). The S2VP10 (pancreatic cancer) cell line was grown in RPMI 1640 (Cellgro 10-
040-CV) with 10% fetal bovine serum (Atlanta Biologicals, GA) and 1% penicillin-streptomycin-glutamine 
solution (HyClone 100X, Thermo Scientific)  in a humidified atmosphere of 5% CO2 at 37˚ C (NAPCO 
Series 8000 DH, Thermo Scientific). Cells were grown in T-75 flasks (Corning, NY) to 80% confluency 
before plated in 3D cell culture formation. Using 24 well round bottom ultra-low attachment plates 
(Corning, NY), 100,000 cells were placed in each well and lightly shaken for ~15 min. Spheroid formation 
occurred after 7-14 days by self-aggregation.  
Nanoparticle Treatment: After optimal 3D cell culture growth was established, 40 μL of 25.0 OD 
(optical density) of each particle type was added to each well. All experiments were done in triplicate. The 
3D cell cultures were incubated for six hours. The remaining media along with any remaining nanoparticles 
were removed from the wells. Each well was washed with 1 mL PBS, and each tumor was transferred to a 
microcentrifuge tube. 
Cryosectioning of in vitro tumors: Cryosectioning was performed using a Leica CM1860 Cryostat. 
For this procedure, tumor spheroids were placed in cryomolds made from Tissue Freezing Medium 
(Triangle Biomedical Sciences).  Once the samples were allowed to dry in the tissue freezing medium for 
two hours, they were sectioned at 5 μM. Settings for the cryostat included a chamber temperature of -20˚ C, 
block temperature of -50˚ C, and sample temperature of -25˚ C. As the samples were sectioned, each 
section was applied to a Superfrost® Plus Microscope Slide (Fischer Scientific, 1255015). Tumor existence 
was confirmed on each slide using an inverted light microscope.
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NANOPARTICLE DETECTION IN 3D CELL CULTURES 
 
 
Detection of Nanoparticles in 3D Cell Culture using Silver Enhancement Stain: After sectioning of 
spheroids, slides were first placed in cold acetone (Fischer Scientific) for 30 sec. Slides were removed from  
acetone and allowed to dry for one minute. Next, slides were placed in 10% formalin buffer (Sigma 
Aldrich) for three minutes. Slides were removed and washed using DI water two times. While slides were 
air dried for five minutes, the silver enhancement solution was prepared by mixing 1 mL/slide Silver 
Enhancement Stain A (Sigma Aldrich, S5070) along with 1 mL/slide Silver Enhancement Stain B (Sigma 
Aldrich S5145). The two solutions were mixed in a 50 mL tube and vortexed for 2 minutes. Next, 2 mL of 
the combined solution was added to each slide and allowed to react for six minutes. The solution was 
washed off using DI water two times after reacting. Slides were analyzed using an NIS Elements AR and 
an Accuscope 3032 inverted light microscope. Using the program, ROI intensity measurements were 
recorded for both the stained and unstained samples.  
Detection of Nanoparticles in 3D Cell Culture using Hyperspectral Imaging: To determine 
nanoparticle diffusion within the 3D cell cultures, the CytoViva Hyperspectral Imaging System was used 
(generously provided by the Department of Bioengineering at the University of Louisville). An Olympus 
BX43, fitted with a condenser from Cytoviva, was utilized for the dark-field microscopy.  Images were 
captured at 60x magnification using the Dage XLMTC optical camera. Samples were prepared by soaking 
in cold acetone, 10% neutral buffer formalin, and dipping in dH2O.  Once the slides were dried, the region 
around the tissue was identified by bright-field microscopy and marked for ease of identification.  A drop 
of oil was placed on the slide and a coverslip attached. Then, a drop of oil was placed on the condenser, and 
the condenser was brought into contact with the slide.  The light source was focused and aligned at 10x 
magnification in order to produce the best quality images.  Another drop of oil was placed on top of the 
coverslip, and an oil-immersion 60x magnification objective was then focused. 
Images were captured at 12-bit resolution at a size of 2048x2048 pixels using Dage Xponent7.  At 
60X magnification, a distance of 1 μm measured to 8.1 pixels.  However, given the light-scattering 
properties of the nanoparticles, they appeared larger than their actual size and were easily identified. Image 
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analysis was performed using NIH ImageJ.  An automatic filtering algorithm was applied to all images, 
which separated out the majority of the particles from the background of tissue. [118]  To ensure that no 
particles were inadvertently filtered, measurements were taken utilizing both the original and the filtered 
image simultaneously. Images of nanoparticles alone were used to determine the average appearance of 
size of the nanoparticles.  A known area of the image was measured, and the ROI intensity was recorded.  
The number of particles was then manually counted, and the ROI intensity was divided by the particle 
count in order to determine the average size particle. 
The number of particles present within a given area was then manually counted, using this average 
particle size for reference in order to form a reasonable estimate in the case of aggregated particles within 
the tissue.  Many different regions were analyzed on each image in order to visualize the diffusion gradient 
of the nanoparticles into the center of the cancer tissues.  The results were then compared internally to 
determine if a particular particle composition and surface modification penetrated the tissue more easily. 
   
 
Figure 3: CytoViva Hyperspectral Imaging. The CytoViva Hyperspectral Imaging system was used to 
confirm the presence of nanoparticles. As shown above, specific spectral profiles were established for the 
nanoparticles alone, tissue alone, and particles within the tissue. Once spectral profiles had been created, 




 Quantification of CytoViva Hyperspectral Imaging Data: Data obtained from the CytoViva 
Hyperspectral Imaging analysis was used to calculate the number of particles present in the outer 50μm 
layer of the spheroid. Diffusion equations were fitted to the data and the total number of particles was 
calculated by integrating the product of the spherical and diffusion equations. For more information, please 
see Results.   
Statistical Analysis: All statistical analyses used the two-tailed Student’s t test with significant 
values being less than 0.05. We used this test because each portion of the study presented one nominal and 
one measureable variable, thus enabling a comparison between the mean values of the measured variables. 
This analysis was sufficient to determine statistical significance within the 95% range. Statistically 







NANOPARTICLE FUNCTIONALIZATION AND CHARACTERIZATION 
 
 
Nanoparticle Characterization: CGN and SGN were layered with either two- or three layers 
(Figure 4) to promote enhanced penetration into 3D cell cultures as a representative model of hypoxic 
regions of solid tumors, and their performance was compared to PEGylated particles. To ensure identity, 
nanoparticles were characterized using UV-Visible spectroscopy, zeta potential analysis, scanning electron 
microscopy, and FTIR. The CGN spectrum was found to have a maximum absorption at 530 nm (Figure 
5A), which is indicative of citrate gold nanoparticles. The SGN spectrum revealed wavelengths in the near 
infrared region around 820 nm (Figure 5B), which is common for nanoshells having 110 nm diameter silica 
cores, along with ~10 nm gold coating [119].   
Zeta potential of nanoparticles refers to the surface charge in solution. Data from previous studies 
provide estimates of expected zeta potential values based upon surface modifications, yet zeta potential is 
dependent on many other factors including size and conformation. In agreement  with previous results, 
PEGylated nanoparticles possessed a zeta potential ranging between -7 to -20 mV [44, 120], the addition of 
–thiol and PC caused an increase in negativity from -20 mV to -30 mV [121], and the addition of HDL 
produced particles with a slightly negative potential [122]. For CGN, the PEGylated control exhibited a 
zeta potential of -9 mV, the two layer particles had -20 mV, and the three layer particle had -2 mV (Figure 
5C). The PEGylated SGN exhibited a zeta potential of -18 mV, the tw o layer nanoshell was -29 mV, and 





Figure 4: Illustration of Functionalized Silica Gold Nanoshells and Citrate Gold Nanoparticles. Six types of 
particles are shown including CGN and SGN. Nanoparticles were functionalized to form PEGylated 





Figure 5. Characterization of SGN and CGN by UV-Visible Spectroscopy and Zeta Potential Analysis. (A) 
Spectra of CGN indicate a maximum absorption at ~535 nm. (B) Spectra of SGN suggests a maximum 
absorption at ~820 nm.  For verification of surface modifications, zeta potential analysis is shown below 
the spectra as an indication of surface charge. (C) PEGylated CGN had a zeta potential of -9 mV, the two 
layer CGN had -20 mV, and the three layer CGN had -2 mV. (D) A zeta potential of -18 mV was found for 







To ensure the presence of surface modifications, fourier transform infrared (FTIR) spectroscopy 
was employed (Figure 6). Spectra obtained were observed and compared to literature sources. For HDL, 
there is an -OH stretch and –CH3 stretch in the 2800-3400 wavenumber/cm
-1
 region with other 
characteristics found in the 1500-1800 wavenumber/cm
-1
 region [123].  For PEGylated nanoparticles, there 
were slight differences in the 1500-1000 wavenumber/cm
-1
 range with three bands assignable to the -CH2 
and -CH3 groups [124]. The FT-IR spectra of PC coated two layer nanoparticles show alterations in the 







Figure 6. Determination of Surface Functionalizing using FTIR.  (Top) Three layer nanoparticles 
containing –thiol, PC, and HDL. (Middle) Two layer nanoparticles containing –TL and PC. (Bottom) 





and others were analyzed to differentiate between lipids and poly(ethylene)glycol. 
 
Scanning electron microscopy was used to further ensure the identity of the nanoparticles (Figure 
7).  Nanoshells had a circular morphology of ~150 nm diameters. Presence of surface modifications was 
detected in the images by the halos surrounding the nanoparticles. The SGN are monodispersed and are less 
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likely to form aggregated. Images of CGN indicated a polydispersed variety of particles including more 
circular and rod-shaped particles. The size of the particles varied from 40 to 75 nm and indicates some 
degree of aggregation. The halo affect can also be seen around the citrate gold nanoparticles indicating the 





Figure 7. Scanning Electron Images of Functionalized Silica Gold Nanoshells and and Citrate Gold 
Nanoparticles. PEGylated silica gold nanoshells (A) indicate particle size to be around 150 nm in diameter. 
Surface modifications of two layer (B) and three layer (C) silica gold nanoshells can be seen by the halo 
effect around the particles. Citrate gold nanoparticles were much smaller than the nanoshells having an 
average diameter of ~50 nm. These particles seemed to form clusters, as did the PEGylated citrate gold 
nanoparticles (D). The polydispersed two layer (E) and three layer (F) were approximately the same size. 
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NANOPARTICLE ACCUMULATION IN 3D CELL CULTURES 
 
Analysis of Nanoparticle Uptake by Silver Enhancement Staining: Use of silver enhancement 
staining for detection of nanoparticles is common practice [126], yet does not provide sufficient 
quantification about the number of particles present in samples (Figure 8). Staining was evaluated using an 
inverted bright field microscope with imaging analysis tools [127]. The results in ROI intensity were 
measured and compared to unstained and stained samples. Differences between unstained samples and 





Figure 8: Detecting Nanoparticle Presence in 3D Cell Cultures through Silver Staining. ROI intensities 
were measured for both unstained sections of tissue and silver stained sections; darker regions denote an 
increase in ROI intensity. 20X image of A549 3D cell culture (A) before and (B) after silver staining. 20X 




Nanoparticle Diffusion through 3D Cell Cultures: In order to determine particle diffusion within 
tumor tissue, ROI measurements were taken at the periphery and center of the 3D cell cultures using the 
silver enhancement stain (Figure 9). In the HepG2 cell line, the largest difference between periphery and 
center regions was exhibited by the two layer CGN (Figure 9A). Two layer SGN presented similar ROI 
intensity values for both the periphery and interior of the 3D cell cultures, suggesting that particles were 
able to diffuse more uniformly into the tissue. Further, these values were the highest of all the cases. Three 
layer CGN also exhibited similar intensities between the periphery and interior of the 3D cell culture, yet at 
lower values indicating poorer penetration.  The PEGylated particles revealed noticeable differences 
between the periphery and the center region while showing the lowest overall uptake.  
In general, the A549 cell line displayed decreased uptake in comparison to the HepG2 3D cell 
cultures (Figure 9B).  Three layer SGN had a more uniform particle distribution while the two layer had 
higher penetration but with an increased differential between the periphery and the interior. Three layer 
CGN exhibited higher ROI and more uniform values as compared to the other CGN. On the other hand, the 
S2VP10 cell line exhibited ROI intensity values highlighting the difficulty for particles to penetrate deeper 
into the 3D cell cultures (Figure 9C), with the peripheries generally having higher ROI values compared to 
the center regions.  The three layer nanoshell had higher uptake in the periphery and center regions as 
compared to the two-layer and PEGylated SGN. Both the two- and three layer CGN presented similar ROI 





Figure 9. ROI Intensity Comparison between 3D Cell Culture Periphery and Inner Regions. ROI intensity 
measurements were taken around the periphery (black bar) and in center regions (grey bar) of the 3D cell 
cultures. Incubation of nanoparticles with two- and three layer CGN and SGN exhibited increased amounts 
of particles on the periphery with a decreased amount towards the center of the tumors. (A) For the HepG2 
3D cell cultures, there are significant differences in the SGN uptake, with the two SGN having an ROI 
intensity of ~100 for both the periphery and center of the 3D cell culture. There are only subtle differences 
for the CGN. (B) For the A549 3D cell cultures, the ROI difference between the edge and center is smaller, 
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while the ROI intensities are less than those seen in panel A. The two layer SGN and three layer CGN 
exhibited higher ROI intensities within the center portions of the 3D cell culture. (C) For the S2VP10 3D 
cell cultures, the three layer SGN presented higher accumulation in the center regions of the 3D cell 
culture, while both the two- and three layer CGN exhibited similar ROI intensity measurements.  
 
To further examine nanoparticle diffusion, 3D cell cultures were examined with dark field 
microscopy (Figure 10). In all cases, the two and three layer particles penetrated deeper and more 
uniformly than the PEGylated particles (Figure 11).  For the HepG2 cell line, the most uniform penetration 
occurred with the three layer CGN and the two layer SGN (Figure 11A-B). For the A549 cell line, the three 
layer CGN outperformed the other CGN, while all the SGN showed similar penetration capabilities 
(Figures 11C-D).  For the S2VP10 cell line, all the cases showed non-uniform penetration, with the three 
layer CGN and SGN having a slight advantage over the other types.  
 
Figure 10: Detection of Nanoparticles within 3D Cell Cultures Using Dark Field Microscopy. Nanoparticle 
uptake was determined using the CytoViva setup with a dark field microscope to visualize the nanoparticles 
and hyperspectral imaging to confirm particle identity. (A) 60X image of 3D cell culture showing increased 
particle concentration around HepG2 3D cell culture periphery with decreasing particle numbers towards 
the inner region. (B) 100X image of A549 3D cell culture illustrating the presence of particles distributed 





Figure 11. Nanoparticle Diffusion into Inner Regions of 3D Cell Cultures. Diffusion of nanoparticles from 
the periphery of 3D cell cultures into inner regions was confirmed using dark field microscopy. On the left, 
CGN are shown while the right column represents SGN. (A) Two layer CGN had the highest particle 
concentration around the periphery with a steep decline into the center regions, whereas the three layer 
particles exhibited a more uniform penetration with higher concentrations within the inner regions. (B) Two 
layer SGN presented a higher and more uniform diffusion from the periphery to the center regions of the 
HepG2 3D cell culture compared to the CGN. (C) The two layer CGN presented uniform penetration in the 
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A549 3D cell cultures. (D) Two layer SGN showed elevated accumulation around the periphery of the 
A549 3D cell cultures, yet with no statistical difference between particle accumulation in the center 
regions. (E) Steep diffusion gradients are shown by (E) CGN and (F) SGN particles in the S2VP10 tumors
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QUANTITATIVE ANALYSIS OF DIFFUSION GRADIENTS 
 
 
 To further analyze diffusion data (Figure 11), diffusion equations were estimated for each particle 
in the three distinct cell lines.  The equations were used to determine the number of particles that were able 
to penetrate and diffuse throughout the 3D cell cultures. Measurements were taken from the periphery to 
the spheroid inward to 50μm. Diffusion data were fitted according to exhibit exponential traits that could be 
used for calculations. Exponential equations were used to calculate the number of particles present in the 
region of spheroid, which is from the periphery to 50μm toward the center as shown (Figure 12). 
 
 
Figure 12: Illustration of Tumor Spheroid Nanoparticle Diffusion. The amount of nanoparticles reaching 
inner portions of the 3D cell culture is much less than those able to penetrate the outer portion of the 








 Two assumptions were made for the calculated to be valid. It was first assumed that all 3D cell 
cultures were spherical in shape, which allowed for simplification of the calculations. It was also assumed 
that all 3D cell cultures were roughly the same size, with the radius being ~400μm. Using these 
assumptions, Equation (1) was used to calculate nanoparticle accumulation.  
 
 
(Equation 1)         ∫           
 
 
   
where N.P. is the number of nanoparticles, a is 350μm, b is 400μm, r is the radius, c and f are constants.  
Diffusion equations (Table 1) were replaced into Equation 1 to ascertain the values found in Table 2. These 
values indicate the total number of nanoparticles within the outer 50μm area around the tumor spheroid (3D 









                                            
 
 
Table 1: Specific Nanoparticle Diffusion Equations. Using the results from Figure 11, equations were determined for the nanoparticles in each 
cell line.  
 








Table 2: Estimated Number of Nanoparticles in the Outer 50μm Section of Spheroid. Using Equation 1 
with the estimated diffusion equations, nanoparticle concentrations were calculated. This illustrates the 
estimated number of nanoparticles within the 50μm. The highest number in each row has been outlined in 
red.  
 
In each cell line, two- layer or three-layer nanoparticles showed optimal accumulation as 
compared to previously designed PEGylated nanoparticles. In HepG2 3D cell cultures,  three-layer CGN 
and two-layer SGN exhibited enhanced accumulation compared to PEGylated nanoparticles (Figure 9 and 
11). For the SGN, the increase in accumulation of two-layer nanoparticles compared to the PEGylated 
nanoparticles was approximately 78%. The CGN depicted a 50% higher accumulation of the three-layer 
nanoparticles compared to the PEGylated nanoparticles. For the A549 cell line (Figure 9 and 11), similar 
results were seen as in the HepG2 cell line. For CGN, three-layer nanoparticle was superior to the 
PEGylated nanoparticle by increasing accumulation by approximately 50%. In the A549 cell line, two-layer 
nanoparticles provided the highest accumulation by approximately 15%, which is much lower than the 
accumulation seen in the HepG2 cell line (78%).  Lastly, the S2VP10 cell line was unique in multiple ways 
(Figure 9 and 11). Both three-layer CGN and SGN presented optimal accumulation compared to the 
PEGylated nanoparticles in S2VP10 cell line. For CGN, there was a 35% increase in comparison to 










Nanotherapeutics offer an enhanced targeting modality for transporting drug at higher 
concentrations into solid tumors. The typically dysfunctional tumor vasculature, however, presents a 
physical obstacle for systemically-administered nanoparticles to reach hypoxic regions.  In this study, we 
designed two and three layer citrate gold (CGN) and silica gold nanoshell (SGN) particles to enhance 
particle diffusion into tumor tissue, using 3D cell cultures to mimic the hypoxic (avascular) regions of solid 
tumors. From this study, we have shown that both PC (two layers) and PC-HDL (three layer) had increased 
accumulation in 3D cell cultures compared to previously synthesized PEGylated nanoparticles. This study 
also demonstrated a cancer-specific uptake of nanoparticles based upon functionalization entities. Lastly, 
this study exhibits the ability to numerically calculate the accumulation of nanoparticles within 3D cell 
cultures, making it an exceptional method for quantifying nanoparticle concentration in vivo. In clinical 
context, quantification can assist in developing specific treatment regimens based upon factors such as 
cancer type, functionalization of particles, and drug related properties.  
The visible spectrum of nanoparticles can be altered by numerous factors including surface 
stabilization, size, shape conformation, and type of dispersion (mono- or poly-) [128-130]. From 
characterizing the particles, verification of the correct chemical synthesis can be ensured. The UV-Visible 
spectra of both the CGN and SGN (Figure 5) were within the expected value range with CGN ~535 nm and 
SGN ~820 nm (nanoshells were modified to the 820 nm wavelength for possible photothermal applications 
in the future [131, 132]).  
Zeta potential (Figure 5) is modulated by surface functionalization and was shown to be ~10 mV 
for the PEGylated particles with two layer particles having increased surface negativity (-20 mV and -29 
mV) and three layer particles possessing more neutral charges. Zeta potentials can have a large impact on 
nanoparticle uptake since cellular membranes also possess negative charges [133, 134]. In this study, we 
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used particles with either neutral or slightly negative charges because particles with positive charges have 
been associated with cell wall disruption and particles with slightly negative charges will circulate 
throughout the body longer than positively charged particles [135]. One way to think about this is to 
remember that cell membranes have a slightly negative fixed charge [136], thus anything that is positive 
will almost instantaneously attract to the cell membranes. Longer circulating particles, those particles 
containing a slightly negative surface charge, will have fewer tendencies to adhere during the first round of 
circulation allowing the active targeting abilities of the nanoparticles to promote tumor uptake as compared 
to normal tissue uptake. Information obtained from the FTIR supported the correct synthesis and 
functionalization of the nanoparticles (Figure 6). Overall, the characterization process ensured the correct 
identity of the nanoparticles used in this study.  
Data from the silver staining and specialized dark field microscopy was used to determine if lipid 
functionalized nanoparticles showed superior accumulation in comparison to PEGylated nanoparticles. In 
Figure 9, the enhanced accumulation of the two- and three-layered nanoparticles compared to the 
PEGylated nanoparticles is clearly visible, with the largest difference presented within the HepG2 cell line. 
The optimized uptake in the liver may be associated with the up-regulation of HDL. Further, the function of 
the liver is to filter materials as well as synthesize PC and HDL, thus the liver may have a higher 
probability of automatically interacting with any particle coated with PC or HDL. Previous studies have 
shown that nanoparticles tend to accumulate in the liver to be excreted through the bile [137, 138]. This 
suggests that hepatocellular cancer and other cancers metastasized to this organ (e.g., colon), may be more 
susceptible to this type of nanoparticle.   
While the hepatocellular 3D cell cultures produced the largest accumulation difference, the lung 
and pancreatic cancer cell lines also demonstrated increased uptake of the two- and three- layer particles, 
especially the nanoshells. This suggests that nanoshells may have enhanced penetration abilities due to 
properties of the nanoparticles such as the silica core size, amount of gold, or increased size. Overall, this 
evidence suggests that the SGN were able to penetrate the tumors as effectively as the CGN, but present a 
much more viable platform for targeted cancer therapy.  Gold nanoshells have tunable optical properties, 
and photothermal treatment has shown to reduce cell viability significantly. [139, 140] 
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This study also demonstrates the ability to numerically determine the amount of particles within a 
tissue sample, such as 3D cell cultures. Using 3D cell cultures or animal tissue, nanoparticle penetration 
and diffusion can be assessed for determining optimal particle type and funtionalization. From Figure 11, 
along with Table 1 and Table 2, nanoparticle accumulation at different locations within 3D cell cultures 
were shown suggesting an increased amount of nanoparticles around the periphery and decreasing particle 
quantities as you move toward the center of the spheroid. Diffusion rates from Figure 11 were used to 
determine the amount of nanoparticles estimated to be within the outer 50 micron region of the 3D cell 
culture. Table 2 clearly indicates that two- and three-layer nanoparticles were superior to PEGylated 
nanoparticles in each cancer line. There were some differences in accumulation of nanoparticles in the 
different cancerous tissue types.  This difference in nanoparticle uptake could also be due to the physical 
morphology of the 3D cell cultures [141, 142].  While the HepG2 and A549 cell lines formed circular 
tumors, the highly metastatic S2VP10 cell line formed cell clusters, which could be a cause for differential 
particle uptake and diffusion.  It is also well known that pancreatic tumors form a dense stroma that may 
hinder interstitial transport [143].  
There are numerous studies showing size-dependent accumulation of nanoparticles within tissue 
samples. Previous studies suggest that CGN exhibit enhanced accumulation in tumors due to their smaller 
size (~30% that of SGN) [128]. Our study does this idea, with CGN accumulation of 135 particles/ 100 μm
2
 
for the periphery and SGN accumulation approximately 95 particles/ 100 μm
2
.  Although ROI intensities 
for both particles were similar, the surface area of one CGN is less than that of one SGN; to obtain similar 
ROI values requires more CGN per area than SGN (Figure 8 and 9).  The smaller size of the CGN may 
therefore make their penetration less dependent on surface modifications, yet CGN are more likely to cause 
toxicity effects due to their solid gold nature (mostly through aggregation) as compared to the nanoshells 
[144].  
This study represents an initial step to assess the performance of two- and three-layered lipid 
coated nanoparticles in penetrating solid tumor tissue.  We find that diffusion gradients of nanoparticles can 
be detected in 3D cell cultures representing hypoxic tumor regions that are poorly vascularized.  While 
nanoparticle diffusion estimates have been made by groups such as Shahid et al. using normalized 
fluorescence values [95, 145], further experimental data is needed to confirm these estimates for further 
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quantification. This study illustrates a method for determining numerical concentrations of nanoparticles 
within tissue, using either 3D cell cultures or in vivo tissue. [139, 140]  As discussed earlier, it is evident 
that two-layer nanoshells provide a clear advantage over PEGylated nanoshells.  In some instances, three-
layer nanoshells exhibited slightly more uptake into the solid tumors; this appeared to be the result of 
cancer-specific interactions.  In conclusion, rather than PEGylating gold nanoshells, modifying the 
nanoshell with PC creates a viable two-layer nanoshell platform that consistently outperforms the current 
standard when measuring particle uptake. The additional modification of HDL also yielded particles 
capable of accumulating in 3D cell culture much better than PEGylated nanoparticles. As such, two- or 
three- layer SGN should be further considered for potential photothermal and targeted drug delivery 
therapies in the fight against cancer. 
 The work will be continued by examining the efficacy of two- and three- layer nanoshell system in 
photothermal applications. In addition, work is currently being done to investigate the potential for 
embedding drugs into the layers of the two- and three layer SGN and CGN for drug delivery.  Our future 
plans include modifying these two- and three- layers nanoparticles with two chemotherapeutic agents, 







SUMMARY AND CONCLUSIONS 
 
Nanotherapeutics offer a novel method for delivering chemotherapeutics to portions of tumor not 
previously accessible to drug alone, while decreasing toxicity and avoiding drug resistance. This project 
consisted of three main stages: development of nanoparticles, functionalization of nanoparticles, and 
determining nanoparticle diffusion with avascular tissue. While many groups have created PEGylated 
nanoparticles to increase circulation time and tumor uptake, we designed lipid encapsulated (also known as 
the two- or three- layered) nanoparticles to optimize their accumulation in tumor tissue. The lipid 
modifications consisted of phosphatidylcholine and high density lipoprotein.  The microenvironment of 
solid tumors contains multiple drug hindering qualities that normally stop nanoparticles and drugs from 
diffusing distant from vasculature.  
This study analyzed the accumulation of nanoparticles using a newly developed methodology 
consisting of a dark field microscopy with specialized hyperspectral imaging. Previous methods included 
the use of attached or entrapped dyes; however exact numerical data could not be obtained from this 
experimental method. Using the CytoViva Hyperspectral Imaging system, we were able to quantify the 
number of nanoparticles at different locations within 3D cell cultures. Using this data, we extrapolated the 
exact number of particles within the spheroid, while also analyzing the decreasing diffusion gradients of the 
nanoparticles from the periphery to center regions. Overall, this method provided significant improvements 
from past methodologies and can provide a deeper insight into nanoparticle and drug diffusion within solid 
tumors. 
The results of this study suggest that lipid-coated nanoparticles (both two- and three-layer) exhibit 
superior penetration and diffusion capabilities compared to PEGylated nanoparticles. For this reason, we 
hypothesize that functionalization of nanoparticles with PC or HDL may be able to increase the 
nanoparticles concentration reaching cancerous tumors in vivo. These lipid functionalized nanoparticles 
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